“…Emerging evidences from published meta-analysis and GWAS studies suggests that several genetic variants (MTHFR, MMP9, PDE4D, CYP4A11, ALOX5P, NOTCH, NINJ2, FGB, eNOS, PITX2, ZFHX3, HDAC9, ABO, etc) have been identified, even though the extent of the effect of each variant is regarded as inter-varying within different populations including Asian, Caucasian, African. [1,1,7,14,[35][36][37][38][39][39][40][41][42][43][44] The findings, however, are often unclear and hard to interpret. Genetic association studies in diverse stroke populations negate matters of the restricted patient population by the a priori choice of a functionally relevant gene and its relation with a specific phenotype.…”